Statistics
| Views | |
|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 593 |
| January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | |
|---|---|---|---|---|---|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 14 | 9 | 3 | 23 | 21 | 22 | 2 |
| Views | |
|---|---|
| TD_2019_debelder_011.pdf | 675 |
| Views | |
|---|---|
| United States | 125 |
| Argentina | 96 |
| Canada | 44 |
| Peru | 35 |
| Mexico | 26 |
| Spain | 20 |
| Colombia | 14 |
| Brazil | 13 |
| Ecuador | 13 |
| Chile | 12 |
| Views | |
|---|---|
| Ottawa | 36 |
| Buenos Aires | 27 |
| Lima | 20 |
| Mexico | 11 |
| Federal | 9 |
| Quito | 9 |
| Tokyo | 9 |
| Hanoi | 8 |
| Houston | 8 |
| Menlo Park | 7 |